Showing results (201-210 of 239) with videos related to
Sort By:
Pageof 24
Anaesthesia|August 1, 2018
An international consensus statement on the management of postoperative anaemia after major surgical proceduresM Muñoz, A G Acheson, E Bisbe, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytesA Anumanthan, A Bensussan, L Boumsell, et al.Clinical Pharmacology and Therapeutics|January 1, 1997
DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartanM R Goldberg, M W Lo, D D Christ, et al.Anaesthesia|January 14, 2024
Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol: a multicentre randomised controlled trialJ Fechner, K El-Boghdadly, D R Spahn, et al.Bioorganic & Medicinal Chemistry Letters|September 30, 2009
Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonistsRainer E Martin, Peter Mohr, Hans Peter Maerki, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2002
Interaction of ritonavir on tissue distribution of a [(14)c]L-valinamide, a potent human immunodeficiency virus-1 protease inhibitor, in rats using quantitative whole-body autoradiographyEric G Solon, Suresh K Balani, Gang Luo, et al.Journal of Medicinal Chemistry|February 12, 2000
4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonistL He, P J Gilligan, R Zaczek, et al.Bioorganic & Medicinal Chemistry Letters|February 20, 2008
Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituentsZhonghui Lu, Gregory R Ott, Rajan Anand, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituentsGregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.Chemmedchem|April 3, 2020
Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRASG12CJérémie Mortier, Anders Friberg, Volker Badock, et al.Pageof 24